Agilent Technologies Inc (A) · Peers
Agilent Technologies against the 24 other companies here in its SEC industry, Laboratory Analytical Instruments. Each figure is the one on the company's own page; the median is the peers', and the rank is among all 25, highest first.
Measure by measure
| Measure | A | Peer median | Rank |
|---|---|---|---|
| Market value | $48.85B | median $373.69M | 1 of 25 |
| P/E | 34.5× | median 48.1× | 6 of 6 |
| Forward P/E | 27.9× | median 32.2× | 7 of 9 |
| EV/EBITDA | 27.3× | median 43.3× | 7 of 8 |
| P/S | 6.8× | median 5.8× | 12 of 24 |
| FCF yield | 2.2% | median -2.0% | 6 of 24 |
| Gross margin | 52.7% | median 47.6% | 8 of 21 |
| Operating margin | 21.5% | median -46.7% | 2 of 22 |
| Net margin | 19.6% | median -12.9% | 2 of 22 |
| ROIC | 14.7% | median -14.2% | 2 of 20 |
| ROE | 19.9% | median -18.0% | 3 of 23 |
| Revenue growth (4y, yearly) | 2.4% | median 5.9% | 14 of 22 |
| EPS growth (yearly) | 3.8% | median -0.9% | 2 of 6 |
| Net debt / EBITDA | 0.7× | median 13.9× | 5 of 5 |
| Current ratio | 3.0× | median 3.7× | 15 of 24 |
| Stock pay / revenue | 1.8% | median 7.6% | 16 of 22 |
| Share count change | -2.1% | median 2.0% | 18 of 22 |
Green where Agilent Technologies is on the better side of the median, red where on the worse; no colour where higher is neither, like size or dividend yield.
The peers, largest first
| Company | Market value | P/E | ROIC | Score |
|---|---|---|---|---|
| AAgilent Technologies Inc | $48.85B | P/E 34.5× | 14.7% | 6.0 |
| WATWaters Corporation | $42.93B | P/E 258.4× | – | 5.5 |
| ILMNIllumina Inc | $39.64B | P/E 48.1× | 32.1% | 5.7 |
| MTDMettler-Toledo International Inc | $32.58B | P/E 36.0× | – | 5.6 |
| RVTYRevvity Inc. | $17.03B | P/E 71.7× | 3.0% | 4.4 |
| AVTRAvantor, Inc. | $11.21B | P/E – | -2.5% | 4.5 |
| BIOBio-RAD Laboratories, Inc. | $9.48B | P/E 42.6× | 0.6% | 5.6 |
| TXG10x Genomics, Inc. | $8.92B | P/E – | -25.5% | 4.6 |
| BRKRBruker Corp | $8.33B | P/E – | -0.6% | 3.9 |
| ALMRAlamar Biosciences, Inc. | $1.75B | P/E – | – | 3.7 |
| CTKBCytek Biosciences, Inc. | $682.41M | P/E – | -14.2% | 4.3 |
| PACBPacific Biosciences of California | $548.62M | P/E – | – | 4.5 |
| MASS908 Devices Inc. | $479.88M | P/E – | -121.9% | 4.9 |
| NAUTNautilus Biotechnology, Inc. | $267.50M | P/E – | -0.9% | 3.5 |
| EYPTEyePoint, Inc. | $257.77M | P/E – | – | 2.5 |
| BFNHBioforce Nanosciences Holdings, Inc. | $231.82M | P/E – | -1.6% | 4.0 |
| QTRXQuanterix Corp | $133.84M | P/E – | -84.1% | 4.4 |
| SEERSeer, Inc. | $112.41M | P/E – | -76.8% | 4.4 |
| PRPOPrecipio, Inc. | $38.85M | P/E – | -14.1% | 5.8 |
| RPIDRapid Micro Biosystems, Inc. | $36.96M | P/E – | -227.4% | 3.8 |
| HBIOHarvard Bioscience Inc | $36.83M | P/E – | -0.5% | 4.6 |
| ASTCASTROTECH Corp | $17.34M | P/E – | -193.8% | 3.2 |
| BNGOBionano Genomics, Inc. | $14.72M | P/E – | -100.2% | 4.5 |
| LCTCLifeloc Technologies, Inc | $8.95M | P/E – | -16.1% | 3.4 |
| SCNDScientific Industries Inc | $8.16M | P/E – | -155.0% | 4.5 |
The industry is the Standard Industrial Classification code the company registered with the SEC. It is a broad label: a peer group is a starting point for comparing, not proof that two businesses are alike. None of this is advice.